Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
101.88
-2.11 (-2.03%)
At close: Mar 30, 2026, 4:00 PM EDT
102.74
+0.86 (0.84%)
Pre-market: Mar 31, 2026, 7:24 AM EDT
Abbott Laboratories Stock Forecast
Stock Price Forecast
The 17 analysts that cover Abbott Laboratories stock have a consensus rating of "Strong Buy" and an average price target of $137.71, which forecasts a 35.17% increase in the stock price over the next year. The lowest target is $120 and the highest is $148.
Price Target: $137.71 (+35.17%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Abbott Laboratories stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 9 | 9 | 7 |
| Buy | 7 | 7 | 7 | 8 | 8 | 8 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 18 | 18 | 19 | 19 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Maintains $140 → $131 | Strong Buy | Maintains | $140 → $131 | +28.58% | Mar 31, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $140 → $136 | Strong Buy | Maintains | $140 → $136 | +33.49% | Mar 11, 2026 |
| Barclays | Barclays | Buy Maintains $169 → $142 | Buy | Maintains | $169 → $142 | +39.38% | Feb 2, 2026 |
| Freedom Broker | Freedom Broker | Hold → Strong Buy Upgrades $130 → $120 | Hold → Strong Buy | Upgrades | $130 → $120 | +17.79% | Jan 29, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $155 → $140 | Strong Buy | Maintains | $155 → $140 | +37.42% | Jan 23, 2026 |
Financial Forecast
Revenue This Year
48.27B
from 44.33B
Increased by 8.90%
Revenue Next Year
51.84B
from 48.27B
Increased by 7.39%
EPS This Year
5.74
from 3.72
Increased by 54.41%
EPS Next Year
6.32
from 5.74
Increased by 9.99%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 50.6B | 54.4B | |||
| Avg | 48.3B | 51.8B | |||
| Low | 46.4B | 49.7B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 14.1% | 12.7% | |||
| Avg | 8.9% | 7.4% | |||
| Low | 4.6% | 3.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 6.06 | 6.70 | |||
| Avg | 5.74 | 6.32 | |||
| Low | 5.52 | 5.97 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 62.9% | 16.6% | |||
| Avg | 54.4% | 10.0% | |||
| Low | 48.3% | 3.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.